Breakfast Show 6:30am - 10:00am

Listen Live

Search

Geneva tests treatment for long-covid

Friday, 18 November 2022 06:30

Pixabay

The Geneva University Hospital is taking part in a trial to test a promising treatment for long-covid.

A Geneva biopharmaceutical company, GeNeuro, has developed an antibody which targets the persistence of inflammation after an infection. 

The trial will last for 6 months and is due to start early next year. Recruitment for test subjects has already begun. Researchers are hoping for around 200 volunteers.

The results should be known in the second half of next year. 

The company says long-covid is associated more with the Delta variant of covid – it seems to be less common with Omicron.

 

Share

More from Bitesize News

  • Govt looks to cut forest protection

    The Federal Council is scrapping the CHF 25 million a year that Parliament voted to help forests adapt to climate change, despite two clear parliamentary decisions.

  • Federal Councillors heckled by protestors

    Federal Councilors were out across the country marking National Day on Saturday - but not without controversy.

  • Further pressure on Swiss football head

    Pressure is mounting on Zurich-based FIFA and its Italo-Swiss president Gianni Infantino after North America's football body demanded a complete overhaul of his presidency.

  • Politicians carry stereotypes

    Elected politicians in Switzerland carry more gender stereotypes than the voters they represent, a new University of Geneva and University of Lausanne study finds.

  • Illegal rave hits pastures

    A thousand young people left a mountain pasture in the Vaud Jura unsuitable for grazing after an illegal rave.

  • More Swiss firefighters head to France

    A second team of 33 firefighters from French speaking Switzerland will travel to south-western France this weekend to relieve colleagues battling the wildfires.

Follow WRS

Download our app

  • Available on the App Store
  • Available on Google Play